Francesc Bosch Albareda

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Francesc Bosch Albareda is an author at Vall d'Hebron Hospital Universitari specializing in immunotherapy, cancer immunotherapy, and relapsed diffuse large b-cell lymphoma.

Publications per year

2017–2021

Publications

Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Martin Hutchings, Anna Sureda, María José Terol et al. · Blood · 2021 · 37 citations

Medicine, Oncology, Pharmacology +12

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Anas Younes, Joshua Brody, Cecilia Carpio et al. · Blood · 2017 · 13 citations

Pharmacy, Oncology, Pharmacology +14

1–2 of 2